ArticleClinical Medicine Insights. Oncology2014

Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel-an Indirect Comparison.

Pui S Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.